Literature DB >> 18793342

Influence of buspirone on gastric sensorimotor function in man.

L Van Oudenhove1, S Kindt, R Vos, B Coulie, J Tack.   

Abstract

BACKGROUND: Previous studies have suggested involvement of 5HT(1) receptors in the control of gastric tone. AIM: To study the effect of buspirone, a 5HT(1A) agonist, on gastric sensorimotor function in healthy volunteers.
METHODS: Ten healthy volunteers (six males and four females, ages 20-29 years) participated in a barostat study evaluating the influence of single oral doses of buspirone (5, 10, 20, 30 and 40 mg) on tone and sensitivity of the proximal stomach. In addition, the effect of placebo or the three lowest doses of buspirone on gastric emptying was assessed using a solid and liquid gastric emptying breath test.
RESULTS: Compared to preadministration volumes, buspirone increased proximal stomach volumes in a dose-dependent manner, with significant fundic relaxation after 30 and 40 mg doses (intra-balloon volume increases of respectively 258 +/- 80 mL and 273 +/- 49 mL, P < or = 0.05). Pressure thresholds during gastric distention were not altered, but corresponding intraballoon volumes were significantly increased after 30 and 40 mg doses (respective discomfort volumes 596 +/- 73 vs. 791 +/- 87 mL and 630 +/- 73 vs.741 +/- 60 mL, both P < 0.05). Buspirone significantly slowed solid and liquid gastric emptying at the 20-mg dose.
CONCLUSION: Buspirone dose-dependently relaxes the proximal stomach in the fasting state and decreases the gastric emptying rate in healthy volunteers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18793342     DOI: 10.1111/j.1365-2036.2008.03849.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  17 in total

1.  Buspirone, a new drug for the management of patients with ineffective esophageal motility?

Authors:  Charlotte Scheerens; Jan Tack; Nathalie Rommel
Journal:  United European Gastroenterol J       Date:  2015-06       Impact factor: 4.623

2.  Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility.

Authors:  Zoltán S Zádori; Ágnes Fehér; Viktória E Tóth; Mahmoud Al-Khrasani; László Köles; Szabina Sipos; Fabio Del Bello; Maria Pigini; Klára Gyires
Journal:  Dig Dis Sci       Date:  2016-02-10       Impact factor: 3.199

3.  Emerging pharmacological therapy for functional dyspepsia.

Authors:  Mariko Hojo; Akihito Nagahara; Daisuke Asaoka; Sumio Watanabe
Journal:  Clin J Gastroenterol       Date:  2013-09-18

4.  Clinical Predictors of Rapid Gastric Emptying in Patients Presenting with Dyspeptic Symptoms.

Authors:  Juan Gomez Cifuentes; Mark Radetic; Rocio Lopez; Scott Gabbard
Journal:  Dig Dis Sci       Date:  2019-04-13       Impact factor: 3.199

Review 5.  Current management strategies and emerging treatments for functional dyspepsia.

Authors:  Michael Camilleri; Vincenzo Stanghellini
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-05       Impact factor: 46.802

6.  Rapid improvement in post-infectious gastroparesis symptoms with mirtazapine.

Authors:  Shinjini Kundu; Shari Rogal; Abdulkader Alam; David J Levinthal
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

7.  Current and Emerging Medical Therapies for Gastroparesis.

Authors:  Xiaofeng Zhao; Hiroshi Mashimo
Journal:  Curr Treat Options Gastroenterol       Date:  2015-12

8.  United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia.

Authors:  Lucas Wauters; Ram Dickman; Vasile Drug; Agata Mulak; Jordi Serra; Paul Enck; Jan Tack; Anna Accarino; Giovanni Barbara; Serhat Bor; Benoit Coffin; Maura Corsetti; Heiko De Schepper; Dan Dumitrascu; Adam Farmer; Guillaume Gourcerol; Goran Hauser; Trygve Hausken; George Karamanolis; Daniel Keszthelyi; Carolin Malagelada; Tomislav Milosavljevic; Jean Muris; Colm O'Morain; Athanassos Papathanasopoulos; Daniel Pohl; Diana Rumyantseva; Giovanni Sarnelli; Edoardo Savarino; Jolien Schol; Arkady Sheptulin; Annemieke Smet; Andreas Stengel; Olga Storonova; Martin Storr; Hans Törnblom; Tim Vanuytsel; Monica Velosa; Marek Waluga; Natalia Zarate; Frank Zerbib
Journal:  United European Gastroenterol J       Date:  2021-04       Impact factor: 4.623

Review 9.  The stomach in health and disease.

Authors:  R H Hunt; M Camilleri; S E Crowe; E M El-Omar; J G Fox; E J Kuipers; P Malfertheiner; K E L McColl; D M Pritchard; M Rugge; A Sonnenberg; K Sugano; J Tack
Journal:  Gut       Date:  2015-09-04       Impact factor: 23.059

Review 10.  Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases.

Authors:  Madhusudan Grover; Michael Camilleri
Journal:  J Gastroenterol       Date:  2012-12-20       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.